305 related articles for article (PubMed ID: 26879401)
1. Medication--related osteonecrosis of the jaws. The first reported cases in the Baltic States and a literature review.
Zaleckas L; Stacevičius M; Proškutė D; Povilaitytė J
Stomatologija; 2015; 17(3):89-96. PubMed ID: 26879401
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
3. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
[TBL] [Abstract][Full Text] [Related]
4. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
6. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
[No Abstract] [Full Text] [Related]
7. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
8. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
[TBL] [Abstract][Full Text] [Related]
9. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
10. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
11. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.
Palla B; Burian E; Deek A; Scott C; Anderson J; Callahan N; Carlson ER
J Oral Maxillofac Surg; 2021 May; 79(5):1045-1052. PubMed ID: 33358707
[TBL] [Abstract][Full Text] [Related]
13. Pain characteristics in medication-related osteonecrosis of the jaws.
Haviv Y; Geller Z; Mazor S; Sharav Y; Keshet N; Zadik Y
Support Care Cancer; 2021 Feb; 29(2):1073-1080. PubMed ID: 32601851
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
McGowan K; Ivanovski S; Acton C
Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R; Woolley J; Patel G; Calasans-Maia MD; Yates J
Br J Oral Maxillofac Surg; 2022 Feb; 60(2):e216-e230. PubMed ID: 35115201
[TBL] [Abstract][Full Text] [Related]
16. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
17. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
[TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.
Parise GK; Costa BN; Nogueira ML; Sassi LM; Schussel JL
Oral Maxillofac Surg; 2023 Sep; 27(3):507-512. PubMed ID: 35739366
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study.
Capocci M; Romeo U; Guerra F; Mannocci A; Tenore G; Annibali S; Ottolenghi L
Clin Ter; 2017; 168(4):e253-e257. PubMed ID: 28703840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
